Screening for hepatocellular carcinoma by Egyptian physicians

Table 8 Relation between highest qualification and knowledge about screening modalities, educational resources and guidelines

	Highest qualification						P value
	MBBCH		Msc/diploma		MD
	n	%	n	%	n	%
Most important screening for HCC							0.023a
Physical examination	0	0	1	2	2	3
Alpha fetoprotein	7	28	13	22	16	23
Ultrasound	14	56	33	55	50	73
CT	4	16	13	22	1	1
2nd most important examination in screening of HCC							0.585
Physical examination	1	4	1	2	0	0
Alpha fetoprotein	12	48	26	43	33	48
Ultrasound	2	8	11	18	8	12
CT	9	36	22	37	27	39
Angiography	1	4	0	0	1	1
3rd most important screening for HCC							0.004a
Physical examination	1	4	3	5	1	1
Alpha fetoprotein	3	12	14	23	17	25
Ultrasound	6	24	2	3	9	13
CT	12	48	25	42	36	52
Angiography	1	4	4	7	6	9
Laparoscopy	2	8	12	20	0	0
Screening interval for high risk group							0.050a
Every 3 mo	15	60	30	50	49	71
6 mo or more	10	40	30	50	20	29
HBV treatment reduces HCC incidence							0.441
Yes	20	80	45	75	58	84
No	5	20	15	25	11	16
Guidelines in management of HCC							0.000a
Yes	13	52	20	33	57	83
No	12	48	40	67	12	17
HCV RNA/ALT risk factors for HCC							0.368
Yes	14	56	37	62	34	49
No	11	44	23	38	35	51

^aP < 0.05 considered statistically significant. HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; CT: Computer tomography.